I deliver profit and operational turnarounds for struggling private companies. I've been successful as Chairman of the Board, as a Board Advisor, and as a member of a Board Financial Audit Committee across diverse industries, with a record of leadership contribution to significantly increase investor value.The combination of my Audit, Compensation, and Governance Board experience in multiple Financial/Operational turnarounds is well-suited to add value to both revenue growth firms and start-up companies.My passion is to forge productive relationships at all organizational levels, both within and outside a company. I drive short-term and long-term P&L through the right combination of organic growth, acquisitions and/or IP commercialization. Highlights include: ► Over 35 years' executive experience in the Specialty Chemicals, Life Sciences/Biotech, Industrial & Automotive, Private Equity and Consumer Products industries. ►10 years' P&L responsibility for companies with $40-$300 million in revenues, coupled with 17 years as SVP for middle-market advisory services. ► Navigating & leading companies through today’s increasing pace of marketplace change, securing needed people, skills & technology, and assembling winning teams.► A leadership style characterized by the rigorous pursuit of a clearly communicated vision, driving superior results through consultation, collaboration and consensus. ► Empowering employees to enable decision-making at the appropriate level, fostering an environment where employees anticipate and benefit from future change, and placing a high priority on developing and promoting from within to develop highly effective teams.► My ability to address changing customer needs, dynamics and markets, ensures that companies build and take to market products and services with a durable competitive advantage.Specialties: CEO, Chief Executive Officer, COO, Chief Operations Officer, SVP, Senior Vice President, VP, Vice President, Director, GM, General Manager, Life Sciences/biotech, Life Sciences, biotech, biotechnology, biomedical, bioresearch devices, devices, commercialization, IP, technology transfer, private equity, financial services, consumer products, consumer goods, leader, leadership, P/L, P&L, profit and loss, turnaround, strategic planning, operations, finance, financial, public, private